Postes actifs de Claresa S. Levetan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Cure DM, Inc.
 Cure DM, Inc. BiotechnologyHealth Technology Cure DM, Inc. operates as a biopharmaceutical company. It develops new therapies that may prevent, ameliorate or reverse diabetes and allow for the discontinuation of insulin. The company was founded by Loraine V. Upham, Claresa S. Levetan and Rita El-Hajj in 2004 and is headquartered in Wilmington, DE. | Fondateur | 01/01/2004 | - |
| Directeur Technique/Scientifique/R&D | 01/01/2004 | - |
Historique de carrière de Claresa S. Levetan
Formation de Claresa S. Levetan
| Emory University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Cure DM, Inc.
Cure DM, Inc. BiotechnologyHealth Technology Cure DM, Inc. operates as a biopharmaceutical company. It develops new therapies that may prevent, ameliorate or reverse diabetes and allow for the discontinuation of insulin. The company was founded by Loraine V. Upham, Claresa S. Levetan and Rita El-Hajj in 2004 and is headquartered in Wilmington, DE. | Health Technology |
- Bourse
- Insiders
- Claresa S. Levetan
- Expérience
